Enanta Pharmaceuticals, Inc. (FRA:9EP)
Germany · Delayed Price · Currency is EUR 10.50
-0.10 (-0.94%)
At close: Jan 28, 2026
Enanta Pharmaceuticals Revenue
In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M USD, down -3.42%. Enanta Pharmaceuticals had revenue of $15.13M in the quarter ending September 30, 2025, with 3.55% growth.
Revenue
$65.32M
Revenue Growth
-3.42%
P/S Ratio
5.66
Revenue / Employee
$544.37K
Employees
120
Market Cap
315.08M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 65.32M | -2.31M | -3.42% |
| Sep 30, 2024 | 67.64M | -11.57M | -14.61% |
| Sep 30, 2023 | 79.20M | -6.96M | -8.07% |
| Sep 30, 2022 | 86.16M | -10.91M | -11.24% |
| Sep 30, 2021 | 97.07M | -25.40M | -20.74% |
| Sep 30, 2020 | 122.47M | -82.72M | -40.31% |
| Sep 30, 2019 | 205.20M | -1.43M | -0.69% |
| Sep 30, 2018 | 206.63M | 103.81M | 100.97% |
| Sep 30, 2017 | 102.81M | 14.55M | 16.48% |
| Sep 30, 2016 | 88.27M | -72.61M | -45.13% |
| Sep 30, 2015 | 160.88M | 113.14M | 236.98% |
| Sep 30, 2014 | 47.74M | 15.69M | 48.94% |
| Sep 30, 2013 | 32.05M | -9.65M | -23.15% |
| Sep 30, 2012 | 41.71M | -176.00K | -0.42% |
| Sep 30, 2011 | 41.88M | 19.12M | 83.99% |
| Sep 30, 2010 | 22.76M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Allane SE | 827.69M |
| SIMONA Aktiengesellschaft | 586.42M |
| centrotherm international AG | 288.81M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 171.37M |
| Novabase S.G.P.S. | 130.35M |
| Wild Bunch AG | 68.86M |
| EUWAX Aktiengesellschaft | 41.42M |
| STINAG Stuttgart Invest AG | 28.92M |